Two of the regions identified in the GWAS (on chromosomes 2 and 8) passed the Bonferroni-adjusted threshold for statistical significance, accounting for multiple testing, and the region on chromosome 2 implicated a gene with compelling candidacy for epilepsy (MAST4) [26–29]. The gene discussed is MAST4; the disease is epilepsy.